Utrophin correlates with disease severity in Duchenne muscular dystrophy

被引：2
|
作者：
Guiraud, Simon [1 ,2 ]
Davies, Kay [3 ]
机构：
[1] Paris Saclay Univ, END ICAP Lab, UVSQ, INSERM,UMR1179, F-78000 Versailles, Paris, France
[2] SQY Therapeut, F-78180 Montigny, France
[3] Univ Oxford, MDUK Oxford Neuromuscular Ctr, Dept Physiol Anat & Genet, Oxford OX1 3PT, England
来源：
MED | 2023年 / 4卷 / 04期
基金：
英国医学研究理事会;
关键词：
D O I：
10.1016/j.medj.2023.03.005
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
This month in Med, the description of an unusually severely affected DMD patient suffering from a large deletion in the dystrophin gene confirms that absence of utrophin worsens the dystrophy and supports the concept that utrophin upregulation ameliorates the pathology. This study may guide the development of dystrophin-based gene therapies.
引用
收藏
页码：220 / 222
页数：3
相关论文
共 50 条
  • [11] Utrophin in the Golden Retriever muscular dystrophy dog model of Duchenne muscular dystrophy.
    Howell, JM
    Davies, L
    Lloyd, F
    BRAIN PATHOLOGY, 2000, 10 (04) : 531 - 532
  • [12] The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy
    Guiraud, Simon
    Edwards, Benjamin
    Babbs, Arran
    Squire, Sarah E.
    Berg, Adam
    Moir, Lee
    Wood, Matthew J.
    Davies, Kay E.
    HUMAN MOLECULAR GENETICS, 2019, 28 (13) : 2189 - 2200
  • [13] Second generation utrophin modulator for the therapy of Duchenne muscular dystrophy
    Guiraud, S.
    Squire, S. E.
    Edwards, B.
    Chen, H.
    Burns, D. T.
    Shah, N.
    Babbs, A.
    Davies, S. G.
    Wynne, G. M.
    Russell, A. J.
    Elsey, D.
    Wilson, F. X.
    Tinsley, J. M.
    Davies, K. E.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S11 - S11
  • [14] Second generation utrophin modulator for the therapy of Duchenne muscular dystrophy
    Guiraud, S.
    Squire, S.
    Edwards, B.
    Chen, H.
    Burns, D.
    Shah, N.
    Babbs, A.
    Davies, S.
    Wynne, G.
    Russell, A.
    Elsey, D.
    Wilson, F.
    Tinsley, J.
    Davies, K.
    NEUROMUSCULAR DISORDERS, 2015, 25 : S260 - S260
  • [15] Second generation utrophin modulator for the treatment of Duchenne muscular dystrophy
    Guiraud, S.
    Squire, S.
    Edwards, B.
    Chen, H.
    Burns, D.
    Shah, N.
    Babbs, A.
    Davies, S.
    Wynne, G.
    Russell, A.
    Elsey, D.
    Wilson, F.
    Harriman, S.
    Tinsley, J.
    Davies, K.
    NEUROMUSCULAR DISORDERS, 2016, 26 : S131 - S131
  • [16] Relationship between utrophin and regenerating fibers in Duchenne muscular dystrophy
    Shim, JY
    Kim, TS
    MODERN PATHOLOGY, 2002, 15 (01) : 302A - 303A
  • [17] Relationship between utrophin and regenerating fibers in Duchenne muscular dystrophy
    Shim, JY
    Kim, TS
    LABORATORY INVESTIGATION, 2002, 82 (01) : 302A - 303A
  • [18] Utrophin expression-patterns and implications for Duchenne muscular dystrophy
    Ehmsen, J
    Weir, A
    Davies, K
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2002, 199 : S31 - S31
  • [19] SPP1 GENOTYPE IS A DETERMINANT OF DISEASE SEVERITY IN DUCHENNE MUSCULAR DYSTROPHY PREDICTING THE SEVERITY OF DUCHENNE MUSCULAR DYSTROPHY: IMPLICATIONS FOR TREATMENT Reply
    Pegoraro, E.
    Hoffman, E. P.
    Piva, L.
    Cagnin, S.
    Lanfranchi, G.
    NEUROLOGY, 2011, 77 (20) : 1858 - 1858
  • [20] Target identification studies of a utrophin modulator for treatment of Duchenne muscular dystrophy
    Wilkinson, Isabel
    Vuorinen, Aini
    Reynolds, Jessica
    Perkins, Kelly
    Dugdale, Hannah
    Squire, Sarah
    Casagrande, Anne-Sophie
    Geese, Marcus
    Wilson, Francis
    Wynne, Graham
    Mohammed, Shabaz
    Huber, Kilian
    Davies, Kay
    Russell, Angela
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2019, 257
12345